Unadjusted patient survival from date of testing positive for SARS-CoV-2, by vaccination status and vaccine type, December 7, 2020, to March 31, 2022. AZ, ChAdOx1-S vaccine; mRNA, either BNT162b2 or mRNA-1273 vaccine; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.